PolyActiva Announces Positive Phase IIa Trial Results in Low D...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
MELBOURNE, Australia, Feb. 18, 2022 /PRNewswire-AsiaNet/ -- - Primary and Secondary Efficacy Endpoints Met, Demonstrating Statistically- Significant Reduction in Intra-Ocular Pressure (IOP) for Patients with GlaucomaPolyActiva Pty Ltd ( https://c212.net/c/link/?t=0&l=en&o=3448237-1&h=1299399622&u=h...
Authors: LATEST ASIANET NEWS RELEASES